Active-ingredient Dossier
Paracetamol
Active-ingredient Dossier for Paracetamol (analgesic antipyretic). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: LOGICIN
- Brand: OSTEOMOL
- Brand: PANADOL
- Brand: PANAMAX
- Brand: PHARMACY
- Brand: PANADEINE
- Therapeutic area: Pain Management
- Therapeutic area: Respiratory
- Therapeutic area: Pain & Anaesthesia
What is
Paracetamol Paracetamol is an analgesic antipyretic.
Australian brands containing
Paracetamol — OSTEOMOL — PANADOL — PANAMAX — PHARMACY — APOHEALTH — PANADEINE — ZALDIAR — AMCAL — ANAGRAINE — APX-PARACETAMOL/CODEINE — ASSISTPRO — BRAUN
Therapeutic areas
Paracetamol is registered in Pain & Anaesthesia (80 brands); Pain Management (44 brands); Respiratory (6 brands); and Complementary Medicine (1 brand).
Sponsor landscape
Paracetamol is marketed by Arrotex Pharmaceuticals, Ipca Pharma, Neo Health (OTC), Nova Pharmaceuticals, Sanofi-Aventis, and Aspen Pharmacare.
PBS and regulatory activity
Four brands containing paracetamol have PBS-listed items, with the latest PBS schedule date of 1 May 2026. In the 2015–16 financial year, PBS expenditure on paracetamol was approximately $67.9 million across 4.9 million prescriptions. The latest PBAC outcome was recorded on 1 July 2020, and the latest AusPAR was published on 11 February 2021.